Annie Liu

Biography

Annie Liu is a member of the Corporate team in our Hong Kong office.

Annie has experience advising clients on mergers and acquisitions, private equity, joint ventures, initial public offerings and other cross-border corporate finance matters. Clients include local, PRC and international law firms, private equity investment institutions, public and private corporations, banks and other financial institutions.

Prior to joining us in 2017, Annie was a member of the M&A corporate team of Clifford Chance, where she was involved in a wide range of cross-border corporate matters with a focus on mergers and acquisitions, private equity and joint venture transactions.

Annie is fluent in Mandarin, Cantonese and English. Her recent transactions include:

  • Advised Coca-Cola on the re-alignment of its mainland China bottling system
  • Advised the purchasing consortium of Lanka Orix Leasing Company and the Bank of East Asia, Limited in the acquisition of a controlling majority stake in PRASAC Microfinance Institution Ltd, Cambodia’s biggest microfinance institution
  • Advised Boyu Capital on its series B and series B+ rounds equity investment into J&T Global Express Limited
  • Advised Tencent on its series G and series H rounds equity investment into Yuanfudao
  • Advised Gaw Capital on various joint venture investments in relation to the set-up of Stellart International School of Arts in Guangzhou, China
  • Advised CITIC Resources Holdings Limited on its disposal of shares in CITIC Dameng Holdings Limited to Youfu Investment Co., Ltd and Fengxiang Investment Co., Ltd
  • Advised TSMC Global Ltd. on issuance of three tranches of bonds
  • Advised C&D Property Management Group Co., Ltd (Stock Code 2156) in relation to the initial public offering of its shares on the Hong Kong Stock Exchange
  • Advised Ganglong China Property Group Limited (Stock Code 6968) in relation to the initial public offering of its shares on the Hong Kong Stock Exchange
  • Advised China Feihe Limited (Stock Code 6186) in relation to the initial public offering of its shares on the Hong Kong Stock Exchange
  • Advised EuroEyes International Eye Clinic Limited (Stock Code 1846) in relation to the initial public offering of its shares on the Hong Kong Stock Exchange
  • Advised Dexin China Holdings Company Limited (Stock Code 2019) in relation to the initial public offering of its shares on the Hong Kong Stock Exchange
  • Advised Legend Biotech Corporation in relation to the initial public offering of its shares on the NASDAQ

Team members